KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Goodwill (2016 - 2025)

Novavax has reported Goodwill over the past 16 years, most recently at $113.5 million for Q4 2025.

  • Quarterly results put Goodwill at $113.5 million for Q4 2025, up 5.57% from a year ago — trailing twelve months through Dec 2025 was $113.5 million (up 5.57% YoY), and the annual figure for FY2025 was $113.5 million, up 5.57%.
  • Goodwill for Q4 2025 was $113.5 million at Novavax, roughly flat from $113.1 million in the prior quarter.
  • Over the last five years, Goodwill for NVAX hit a ceiling of $134.3 million in Q2 2021 and a floor of $107.5 million in Q4 2024.
  • Median Goodwill over the past 5 years was $125.1 million (2022), compared with a mean of $123.4 million.
  • Biggest five-year swings in Goodwill: skyrocketed 161.82% in 2021 and later decreased 15.67% in 2024.
  • Novavax's Goodwill stood at $131.5 million in 2021, then decreased by 3.92% to $126.3 million in 2022, then increased by 0.89% to $127.5 million in 2023, then fell by 15.67% to $107.5 million in 2024, then increased by 5.57% to $113.5 million in 2025.
  • The last three reported values for Goodwill were $113.5 million (Q4 2025), $113.1 million (Q3 2025), and $113.0 million (Q2 2025) per Business Quant data.